Lavipharm S.A (LAVI) — Cash Flow-to-Debt Ratio
Lavipharm S.A (LAVI) has a Cash Flow-to-Debt Ratio of 0.01x as of December 2022, meaning its operating cash flow of €527.00K could theoretically repay 0% of its total liabilities (€73.89 Million) in one year. Explore how much of Lavipharm S.A's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Lavipharm S.A Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Lavipharm S.A across 11 annual periods. Also explore LAVI asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Lavipharm S.A (2014–2024)
Year-by-year debt coverage analysis for Lavipharm S.A. For market capitalisation and broader financial context, see market value of Lavipharm S.A.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.06x | €4.64 Million | €72.52 Million | ▲ +1522.5% |
| 2023 | 0.00x | €284.00K | €72.02 Million | ▼ -91.3% |
| 2022 | 0.05x | €3.35 Million | €73.89 Million | ▼ -25.7% |
| 2021 | 0.06x | €3.82 Million | €62.68 Million | ▲ +34.6% |
| 2020 | 0.05x | €2.85 Million | €62.94 Million | ▼ -0.1% |
| 2019 | 0.05x | €2.89 Million | €63.82 Million | ▲ +96.5% |
| 2018 | 0.02x | €1.42 Million | €61.43 Million | ▼ -1.4% |
| 2017 | 0.02x | €1.51 Million | €64.73 Million | ▲ +208.8% |
| 2016 | 0.01x | €606.00K | €80.00 Million | ▲ +93.1% |
| 2015 | 0.00x | €576.00K | €146.80 Million | ▼ -78.1% |
| 2014 | 0.02x | €2.38 Million | €132.79 Million | — |